The BioMe Phenomics Center at the Icahn School of Medicine at Mount Sinai (BPC) aims to bridge the gap between genetics and medical traits. To achieve this, we combine genetic information obtained from the BioMe Biobank with rigorous screening and testing for medical disorders.
The deep phenotyping core of the Mount Sinai BPC serves as a catalyst to empower translational science, generate resources for internal and external investigators and engender profitable interactions with industry partners.
We perform medical tests that aid in the diagnosis or detection of diseases and measure the progress of the disease. Our services range from blood testing like complete blood count, lipid profile to urine testing, cardiac testing, anthropometric testing and eye testing.
Our mission is to develop a center for recontact of BioMe participants for deeper phenotyping and biospecimen storage. BPC will make available to the Mount Sinai faculty, outside academic institutions, and industry partners the list of genes with penetrant homozygous LoF mutations that can be leveraged for recontacting and phenotyping studies.
"The BioMe Phenomics Center is a revolutionary initiative towards empowering translational science. Our radical project is leading the way in providing us with an unprecedented opportunity to understand the effect of genetic perturbations on phenotypic traits, and discovering useful safety information during the earliest stages for novel therapeutics. " – Judy H. Cho, MD; Girish Nadkarni, MD; Ron Do, PhD; Co-Directors BioMe Phenomics Center